drugset / Trial / NCT05716919
Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule
RandomizedSequentialDouble-blindTreatment
Summary
A Phase I, Double blind, Randomized, Placebo-controlled, Multiple Ascending Dose Study to evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Orally Administered 'CG-745' Capsule in Healthy Male Volunteers
Timeline
- Start
- 2023-03-09
- Primary completion
- 2023-12
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CG200745 | Small molecule | 50 mg | Oral |
| Subject | CG200745 | Small molecule | 100 mg | Oral |
| Subject | CG200745 | Small molecule | 200 mg | Oral |
| Subject | CG200745 | Small molecule | 300 mg | Oral |